F.D.A. Approves a Bone Drug for Cancer Patients
Considering the FDA’s previous approvals on Boniva and Fosamax for bone strength turned out to be full of harm (causing bone loss), why would you trust your health to this latest approval?
~ Uncle Russ
The Food and Drug Administration on Thursday approved the use of Amgen’s bone drug denosumab as a treatment for cancer patients whose disease has spread to their bones.